- $31.78bn
- $32.97bn
- $7.36bn
- 98
- 28
- 84
- 80
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 5,249 | 4,876 | 5,195 | 5,522 | 7,364 |
Cost of Revenue | |||||
Gross Profit | 2,046 | 1,830 | 1,975 | 2,084 | 2,717 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 4,762 | 4,509 | 4,608 | 5,039 | 6,713 |
Operating Profit | 487 | 367 | 587 | 483 | 651 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 416 | 285 | 511 | 440 | 635 |
Provision for Income Taxes | |||||
Net Income After Taxes | 401 | 254 | 427 | 355 | 609 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 401 | 254 | 427 | 355 | 609 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 401 | 254 | 427 | 355 | 609 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.84 | 2.7 | 2.44 | 2.95 | 3.86 |
Dividends per Share |